Contract 75D30121D10191
Sanofi Vaccines Us Inc. · Department Of Health And Human Services · September 24, 2021
Sanofi Vaccines Us Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on September 24, 2021 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $144.43 million.
Contract details
- PIID
- 75D30121D10191
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 24, 2021
Description
FLU VACCINE
Modification timeline
-
September 24, 2021Mod P00003 · Other Administrative Action$86.99M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30121D10191?
Contract 75D30121D10191 is a federal contract awarded to Sanofi Vaccines Us Inc. by Department Of Health And Human Services on September 24, 2021 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75D30121D10191?
Sanofi Vaccines Us Inc. won contract 75D30121D10191 from Department Of Health And Human Services.
How much is contract 75D30121D10191 worth?
Contract 75D30121D10191 has obligated $0 to date but carries a potential ceiling of $144.43 million if fully funded and all options are exercised.